Epizyme reported $9.86M in Trade Creditors for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Trade Creditors Change
Agios Pharmaceuticals AGIO:US $ 10.31M 2.65M
Amarin AMRN:US $ 72.42M 68.84M
Amgen AMGN:US $ 1171M 106M
Avrobio Inc AVRO:US 2.97M 937K
Biogen BIIB:US $ 427.9M 52.6M
Bluebird Bio BLUE:US $ 21.67M 17.63M
Cerulean Pharma CERU:US $ 605.73K 389.69K
Daiichi Sankyo 4568:JP Y 265499M 1396M
Eisai 4523:JP Y 76277M 4499M
Epizyme EPZM:US $ 9.86M 2.57M
Exelixis EXEL:US $ 24.31M 3.86M
Karyopharm Therapeutics KPTI:US $ 881K 1.43M
Macrogenics MGNX:US $ 6.17M 3.65M
Mirati Therapeutics MRTX:US $ 42.92M 19.05M
Novartis NOVN:VX 4.66B 146M
Novartis NVS:US $ 4665M 146M
Regeneron Pharmaceuticals REGN:US $ 427M 49M
Seattle Genetics SGEN:US $ 109.96M 7.55M
Spectrum Pharmaceuticals SPPI:US $ 40.91M 0.95M
Vertex Pharmaceuticals VRTX:US $ 127.86M 0.33M
Xencor XNCR:US $ 9.13M 2.02M